Pfizer Purchases Hematology Company

After gaining an increased profit from the COVID-19 vaccine, Pfizer has been using its expanded income to expand its business.

The company's latest acquisition: Global Blood Therapeutics.

Global Blood Therapeutics made tablets for treating sickle cell disease, an inherited red blood cell disorder.